Skip to main content
. 2015 Jul 27;2015:616747. doi: 10.1155/2015/616747

Table 1.

Patients characteristics.

All patients (N = 181) Macrovascular complications
(N = 46)
P a Microvascular complications (N = 34) P b
Male genderc 105 (58.0) 29 (63.0) 0.423d 23 (67.6) 0.206d
Age (years) 64.0 (58.5–70.5) 64.0 (58.8–72.3) 0.495 64.0 (58.0–75.3) 0.251
Duration of T2D (years) 11.0 (6.0–17.0) 16.0 (7.0–23.5) 0.003 20.5 (11.0–27.0) 0.000
HbA1c (%) [mmol/mol] 6.9 (6.3–7.6) [52 (45–60)] 6.7 (5.9–7.4) [50 (41–57)] 0.143 6.5 (5.8–7.7) [48 (40–61)] 0.020
BMI (kg/m2) 30.0 (28.0–33.3) 30.0 (27.0–33.1) 0.741 29 (25.8–32.4) 0.191
Blood pressure systolic (mmHg) 135.0 (130.0–145.0) 140.0 (128.8–150.5) 0.257 139.0 (119.3–149.0) 0.759
Blood pressure diastolic (mmHg) 80.0 (70.0–80.0) 75.0 (65.8–80.0) 0.014 72.0 (63.0–80.0) 0.000
Total cholesterol (mmol/L) 4.2 (3.5–5.0) 3.9 (3.1–4.5) 0.004 3.7 (2.9–4.7) 0.002
LDL cholesterol (mmol/L) 2.4 (1.9–3.1) 2.3 (1.5–2.7) 0.047 2.0 (1.5–2.4) 0.004
HDL cholesterol (mmol/L) 1.1 (1.0–1.4) 1.1 (0.9–1.3) 0.009 1.1 (0.9–1.4) 0.323
TAG (mmol/L) 1.6 (1.2–2.4) 1.7 (1.1–2.2) 0.587 1.3 (0.9–2.1) 0.046

aComparison between patients with and without macrovascular complications. bComparison between patients with and without microvascular complications.

Data are shown as median (25%–75%), except for c N (%). P values were calculated using Mann-Whitney test, except for dchi square test.